KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to -$110.0 million.

  • West Pharmaceutical Services' Other Working Capital Changes fell 15462.96% to -$110.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$108.1 million, marking a year-over-year decrease of 37831.86%. This contributed to the annual value of -$108.1 million for FY2025, which is 37831.86% down from last year.
  • West Pharmaceutical Services' Other Working Capital Changes amounted to -$110.0 million in Q4 2025, which was down 15462.96% from -$2.1 million recorded in Q3 2025.
  • West Pharmaceutical Services' Other Working Capital Changes' 5-year high stood at $94.9 million during Q1 2021, with a 5-year trough of -$185.4 million in Q4 2022.
  • In the last 5 years, West Pharmaceutical Services' Other Working Capital Changes had a median value of $0.0 in 2024 and averaged -$7.8 million.
  • The largest annual percentage gain for West Pharmaceutical Services' Other Working Capital Changes in the last 5 years was 28083.54% (2021), contrasted with its biggest fall of 338260.87% (2021).
  • Over the past 5 years, West Pharmaceutical Services' Other Working Capital Changes (Quarter) stood at -$10.2 million in 2021, then crashed by 1717.65% to -$185.4 million in 2022, then surged by 85.98% to -$26.0 million in 2023, then crashed by 66.15% to -$43.2 million in 2024, then tumbled by 154.63% to -$110.0 million in 2025.
  • Its Other Working Capital Changes was -$110.0 million in Q4 2025, compared to -$2.1 million in Q3 2025 and $4.1 million in Q2 2025.